Raquibul Hannan, M.D., Ph.D., Chief of Genitourinary Radiation Oncology Service
Genitourinary Cancer
New Patient Appointment or 214-645-8525
Few centers have our breadth of treatment options for patients. A key strength of our group is the ability, expertise, and desire to individualize treatment strategy to the patient. As an early adopter and developer of radiation technologies, we offer many treatment modalities, including brachytherapy (radioactive seed implant), stereotactic body radiotherapy (SBRT), image-guided intensity modulated radiotherapy (IG-IMRT), volumetric modulated arc therapy (VMAT), and more.
Meet Our Team
Neil Desai, M.D., M.H.S.
Tamara Dickinson, M.S.N., APRN, AGPCNP-BC, CURN, CCCN
Aurelie Garant, M.D.
Shay Rezaie, M.S.N., APRN, FNP-C, OCN
Andrew Wang, M.D.
Daniel Yang, M.D.
Educational Materials
General
- Genitourinary cancer FAQ (English, Spanish)
- Pelvic floor exercises for men (English, Spanish)
- Penile compression devices (English, Spanish)
- Bladder and bowel prep for CT scan (English, Spanish)
- Full bladder prep for simulation and treatment (English, Spanish)
Bladder Cancer
Kidney Cancer
Prostate Cancer
- Radiation treatment for prostate cancer (English, Spanish)
- SBRT for prostate cancer (English, Spanish)
- Brachytherapy for prostate cancer (English, Spanish)
- Rectal spacer procedure (English, Spanish)
Testicular Cancer
Bladder and Bowel Prep for CT Scan
Dr. Neil Desai and Jennifer Cleaton, chief therapist, discuss the bladder and bowel prep for CT scans.
Simulation Visit
Dr. Aurelie Garant discusses what you can expect during your simulation visit prior to your radiation treatments.
SpaceOAR Hydrogel Spacer Procedure
Dr. Neil Desai discusses the SpaceOAR hydrogel spacer and what you can expect during and after the procedure.
Patient Story
Kevin Stanfield came to UT Southwestern after learning he had prostate cancer. He enrolled in the POTEN-C trial and was treated by Dr. Desai.
GU Clinical Trials
As one of the top academic medical centers in the country and the only NCI-designated cancer center in North Texas, we lead and participate in a number of clinical trials aimed at improving the outcomes of patients with cancer. Our Department enrolls approximately 200 new patients in clinical trials each year.
Clinical trials are critical in developing new therapies for cancer and can mean having access to new medication, groundbreaking research, and additional clinical care. Our clinical trials team is comprised of radiation oncologists, radiation biologists, clinical research coordinators, quality assurance coordinators, and clinical data specialists.
Therapeutic
STU 2021.1091 (NRG-GU010) Parallel Phase III Randomized Trial of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensificiation and Intensification Clinical Trial Evaluation (GUIDANCE).
STU 2023.0566 (PULSAR PROPhET) Phase 1B Study of Personalized Ultrahypofractionated Stereotactic Ablative Radiotherapy of High-Risk PROstate Cancer Guided by PET PSMA (68Ga PMSA-11; Ilucix) Response (PULSAR ProPhet).
STU 2024.0024 A Study of a Non-Significant Risk (NSR) Device: [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on the RefleXion X1 System in Patients Already Undergoing Diagnostic PET PSMA Imaging.
If you’re interested in a clinical trial, please talk to your doctor.
Learn more about clinical trials.
NRG GU010 Clinical Trial
NRG-GU010 is a clinical study for men with unfavorable intermediate risk prostate cancer that provides treatment options based on gene risk score. Learn more.
Overview of the NRG-GU010 Clinical Trial
De-intensification
Intensification
Helpful Resources
Our patients share their stories and experiences within the Department of Radiation Oncology at UT Southwestern.
Radiation therapy can sound frightening, but we’re here to guide patients throughout their journey. From our dedicated team of physicians and therapists to dietitians and social services, we can help with any questions or concerns.
We offer a variety of support services to help those with cancer and their families.